Sylvia Ounpuu

Ms. Sylvia Ounpuu

1. Center for Motion Analysis, Connecticut Children’s Medical Center, 399 Farmington Ave., Farmington, CT 05032, USA
+1

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2015 in Gait & Posture
Verified
Journal Article
Closed access
Sylvia OunpuuSylvia Ounpuu
Sylvia Ounpuu
MSMatthew Solomito
Matthew Solomito
KBKatharine Bell
Katharine Bell
PDPeter DeLuca
Peter DeLuca
KPKristan Pierz
Kristan Pierz

28 April 2015 in Developmental Medicine & Child Neurology
Verified
Journal Article
Open access
PDF file
Sylvia OunpuuSylvia Ounpuu
Sylvia Ounpuu
GGGeorge Gorton
George Gorton
ABAnita Bagley
Anita Bagley
MSMitell Sison‐Williamson
Mitell Sison‐Williamson
SHSahar Hassani
Sahar Hassani
DODonna Oeffinger
Donna Oeffinger
Aim: The aim of this study was to examine differences in gait kinematics and spatiotemporal parameters in ambulatory children and adolescents with bilateral spastic cerebral palsy (BSCP) among Gross Motor Function Classification System (GMFCS) levels I‐III.Method: A retrospective review was conducted of individuals with BSCP who had three‐dimensional motion analysis (3DGA) at one of seven pediatric hospitals. Means and standard deviations of each gait parameter were stratified by GMFCS levels (I‐III) and for a typically developing comparison group.Results: Data from 292 children and adolescents with BSCP (189 males, 103 females; mean age 13y) were compared to a typically developing comparison group (24 male, 26 female; mean age 10y 6mo). Gait patterns differed from typically developing in all GMFCS levels, with increasing deviation as GMFCS level increased in 21 out of 28 parameters. Despite significant differences in selected mean kinematic parameters among GMFCS levels such as knee angle at initial contact of 24°, 29°, and 41° in GMFCS levels I, II and III respectively, there was also substantial overlap among GMFCS levels.Interpretation: GMFCS levels cannot be identified using specific gait kinematics. Treatment decisions should be guided by comprehensive 3DGA that allows measurement of gait impairments at the joint level for each individual.

1 July 2017 in Gait & Posture
Verified
Journal Article
Closed access
Sylvia OunpuuSylvia Ounpuu
Sylvia Ounpuu
MSMatthew Solomito
Matthew Solomito
KBKatharine Bell
Katharine Bell
KPKristan Pierz
Kristan Pierz

1 March 2021 in Gait & Posture
Verified
Journal Article
Closed access
Sylvia OunpuuSylvia Ounpuu
Sylvia Ounpuu
EGErin Garibay
Erin Garibay
GAGyula Acsadi
Gyula Acsadi
MBMichael Brimacombe
Michael Brimacombe
KPKristan Pierz
Kristan Pierz

1 January 2020 in Gait & Posture
Verified
Journal Article
Closed access
KPKristan A. Pierz
Kristan A. Pierz
JLJessica R. Lloyd
Jessica R. Lloyd
MSMatthew J. Solomito
Matthew J. Solomito
PMPhil Mack
Phil Mack
Sylvia OunpuuSylvia Ounpuu
Sylvia Ounpuu

3 October 2025 in Bioengineering
Verified
Journal Article
Open access
PDF file
Gordon AlderinkGordon Alderink
Gordon Alderink
Sylvia OunpuuSylvia Ounpuu
Sylvia Ounpuu
A review of the methods and applications of marker-based and markerless-based motion capture and inertial measurement units for clinical gait analysis is offered to provide readers with an important historical and legacy-guided perspective. Advantages and limitations of these methods are delineated in light of Cappozzo’s ‘considerations on clinical gait evaluation’ and Brand and Crowninshield’s ‘comment on criteria for patient evaluation tools’. Critical summaries of each manuscript that make up this Special Issue reflect consideration of the notable comments by the legacy biomechanists who had the insights to frame important issues.